中国实用眼科杂志
中國實用眼科雜誌
중국실용안과잡지
CHINESE JOURNAL OF PRACTICAL OPHTHALMOLOGY
2014年
3期
297-300
,共4页
微创玻璃体切割术%23G%视网膜静脉阻塞%玻璃体积血
微創玻璃體切割術%23G%視網膜靜脈阻塞%玻璃體積血
미창파리체절할술%23G%시망막정맥조새%파리체적혈
Minimally invasive vitreous excision%23-gauge%Retinal vein occlusion%Vitreous hemorrhage
目的 探讨23 G微创玻璃体切割手术治疗视网膜静脉阻塞(RVO)性玻璃体积血的有效性及安全性.方法 回顾性分析对2011年6月至2012年12月在南昌大学第二附属医院眼科行手术治疗的视网膜静脉阻塞(RVO)性玻璃体积血患者62例62只眼.所有患者均采用23 G微创玻璃体切割术,术中行眼内激光光凝,术毕玻璃体腔填充玻璃体切割灌注液、空气、C3F8或者硅油.术后随访5～23个月,平均16.2个月;观察记录最佳矫正视力、眼压、术中术后并发症等发生情况,对记录数据进行统计学分析比较.结果 62例62只眼中有56只眼手术后随访发现视力较术前不同程度提高,占90.3％,6只眼术后视力保持不变(9.7％).所有病例中视网膜中央静脉阻塞(CRVO)术后随访时最佳矫正视力为指数20 cm～0.25,与术前相比差异无统计学意义(t=1.623,P＞0.10);视网膜分支静脉阻塞(BRVO)术后随访时最佳矫正视力为0.02～0.6,与术前相比差异有统计学意义(t=-2.816,P ＜0.01).所有病例术前眼压为8.4～20.1 mmHg,末次随访时的眼压为9.1～19.2 mmHg,差异无统计学意义(t =-1.042,P＞0.20).所有病例术中及术后未见严重相关并发症发生.结论 23G微创玻璃体切割术治疗视网膜静脉阻塞(RVO)性玻璃体积血具有良好地临床疗效,是一种安全有效地治疗方法.
目的 探討23 G微創玻璃體切割手術治療視網膜靜脈阻塞(RVO)性玻璃體積血的有效性及安全性.方法 迴顧性分析對2011年6月至2012年12月在南昌大學第二附屬醫院眼科行手術治療的視網膜靜脈阻塞(RVO)性玻璃體積血患者62例62隻眼.所有患者均採用23 G微創玻璃體切割術,術中行眼內激光光凝,術畢玻璃體腔填充玻璃體切割灌註液、空氣、C3F8或者硅油.術後隨訪5～23箇月,平均16.2箇月;觀察記錄最佳矯正視力、眼壓、術中術後併髮癥等髮生情況,對記錄數據進行統計學分析比較.結果 62例62隻眼中有56隻眼手術後隨訪髮現視力較術前不同程度提高,佔90.3％,6隻眼術後視力保持不變(9.7％).所有病例中視網膜中央靜脈阻塞(CRVO)術後隨訪時最佳矯正視力為指數20 cm～0.25,與術前相比差異無統計學意義(t=1.623,P＞0.10);視網膜分支靜脈阻塞(BRVO)術後隨訪時最佳矯正視力為0.02～0.6,與術前相比差異有統計學意義(t=-2.816,P ＜0.01).所有病例術前眼壓為8.4～20.1 mmHg,末次隨訪時的眼壓為9.1～19.2 mmHg,差異無統計學意義(t =-1.042,P＞0.20).所有病例術中及術後未見嚴重相關併髮癥髮生.結論 23G微創玻璃體切割術治療視網膜靜脈阻塞(RVO)性玻璃體積血具有良好地臨床療效,是一種安全有效地治療方法.
목적 탐토23 G미창파리체절할수술치료시망막정맥조새(RVO)성파리체적혈적유효성급안전성.방법 회고성분석대2011년6월지2012년12월재남창대학제이부속의원안과행수술치료적시망막정맥조새(RVO)성파리체적혈환자62례62지안.소유환자균채용23 G미창파리체절할술,술중행안내격광광응,술필파리체강전충파리체절할관주액、공기、C3F8혹자규유.술후수방5～23개월,평균16.2개월;관찰기록최가교정시력、안압、술중술후병발증등발생정황,대기록수거진행통계학분석비교.결과 62례62지안중유56지안수술후수방발현시력교술전불동정도제고,점90.3％,6지안술후시력보지불변(9.7％).소유병례중시망막중앙정맥조새(CRVO)술후수방시최가교정시력위지수20 cm～0.25,여술전상비차이무통계학의의(t=1.623,P＞0.10);시망막분지정맥조새(BRVO)술후수방시최가교정시력위0.02～0.6,여술전상비차이유통계학의의(t=-2.816,P ＜0.01).소유병례술전안압위8.4～20.1 mmHg,말차수방시적안압위9.1～19.2 mmHg,차이무통계학의의(t =-1.042,P＞0.20).소유병례술중급술후미견엄중상관병발증발생.결론 23G미창파리체절할술치료시망막정맥조새(RVO)성파리체적혈구유량호지림상료효,시일충안전유효지치료방법.
Objective To investigate the safety and efficacy of 23-gauge minimally invasive vitrectomy for vitreous hemorrhage resulted form retinal vein occlusion (RVO).Methods A retrospective analysis 62 eyes of 62 patients with vitreous hemorrhage resulted form RVO who underwent 23 G minimally invasive vitrectomy and endophotocoagulation.All patients were followed up for 5-23 months,meanly 16.2 months.Main outcome measures included the best corrected visual acuity (BC-VA),intraocular pressure (IOP),intraoperative and postoperative complications,and the data were statistically analyzed and compared.Results The BCVA increased in 56 eyes (90.3％),remained in 6 eyes (9.7％).The postoperative BCVA of the central retinal vein occlusion (CRVO) ranged from counting fingers/20cm to 0.25 and there wasn't a significant statistical difference between pre-operation and post-operation (t =-1.623,P ＞0.10).The postoperative BCVA of the branch retinal vein occlusion (BRVO) ranged from 0.02 to 0.6,there was a significant statistical difference between pre-operation and post-operation (t-=-2.816,P ＜0.01).The difference of IOP between pre-operation (8.4-20.1mmHg) and the last follow-up (9.1～19.2mmHg) was not statistically significant (t=-1.042,P ＞0.20).There were no serious complications.Conclusions 23 G minimally invasive vitrectomy is a safe and effective treatment for vitreous hemorrhage resulted form RVO.
